Loading
Demographics/Lifestyle Survey / Metastatic Breast Cancer · Interventional Study
ClinicalTrials.gov · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned single-center interventional study of a group-based comprehensive lifestyle program (ACLP) in women with stable HR+/HER2− metastatic breast cancer, designed primarily to evaluate safety and adverse events over approximately one year. No results have been posted; recruitment has not yet begun.
Interventional, Non Randomized, Single Group, Open label, Supportive Care purpose. Metastatic Breast Cancer; Female; age from 18 Years. Intervention: ACLP Program; ACLP Program + Learning Circles; ACLP Program + Learning Circles + Individual Health Coaching. n = 100. 1 site: United States.
This is a planned single-center interventional study of a group-based comprehensive lifestyle program (ACLP) in women with stable HR+/HER2− metastatic breast cancer, designed primarily to evaluate safety and adverse events over approximately one year. No results have been posted; recruitment has not yet begun.
Phase designation is 'NA'; study objectives beyond safety assessment are not specified in the registry entry.
The source did not state who this applies to in practice.
This is a registry record for a planned interventional study with no results posted; enrollment has not yet begun, making it a feasibility and safety assessment in an understudied population.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07179809). This is a study registration, not published results. Lead sponsor: M.D. Anderson Cancer Center. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 100 participants (ESTIMATED). Conditions: Metastatic Breast Cancer. Interventions: OTHER: Demographics/Lifestyle Survey. Primary outcome measures: Safety and Adverse Events (AEs) , Through study completion; an average of 1 year.. Brief summary: The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.